(RTTNews) - Biogen Inc. (BIIB) said that the European Commission has approved a new intramuscular or IM injection route of administration for Plegridy or peginterferon beta-1a for the treatment of ...
CAMBRIDGE, Mass., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has approved a new intramuscular (IM) injection route of ...
Fingolimod (FTY720), a sphingosine-1-phosphate–receptor modulator that prevents lymphocyte egress from lymph nodes, showed clinical efficacy and improvement on imaging in a phase 2 study involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results